<i>Lactobacillus acidophilus</i> DDS-1 and <i>Bifidobacterium lactis</i> UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial

<i>Lactobacillus acidophilus</i> DDS-1 and <i>Bifidobacterium lactis</i> UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial

This randomized, double-blind, placebo-controlled, multi-center study investigated the clinical efficacy of two probiotic strains on abdominal pain severity and symptomology in irritable bowel syndrome (IBS). Three hundred and thirty adults, aged 18 to 70 years, with IBS according to Rome IV criteri...

Full description

Bibliographic Details
Main Authors: Christopher J. Martoni, Shalini Srivastava, Gregory J. Leyer
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Nutrients
Subjects:
randomized controlled trial
irritable bowel syndrome
probiotic
abdominal pain
bowel habits
microbiome
Online Access:https://www.mdpi.com/2072-6643/12/2/363

Internet

https://www.mdpi.com/2072-6643/12/2/363

Similar Items